CEMTREX INC (CETX) Fundamental Analysis & Valuation

NASDAQ:CETX • US15130G8731

Current stock price

1.2201 USD
-0.07 (-5.42%)
Last:

This CETX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CETX Profitability Analysis

1.1 Basic Checks

  • CETX had negative earnings in the past year.
  • In the past year CETX had a positive cash flow from operations.
  • CETX had negative earnings in each of the past 5 years.
  • In the past 5 years CETX reported 4 times negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • CETX has a Return On Assets of -33.01%. This is in the lower half of the industry: CETX underperforms 79.03% of its industry peers.
  • CETX has a Return On Equity of -68.46%. This is in the lower half of the industry: CETX underperforms 79.84% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.80%, CETX is in line with its industry, outperforming 46.77% of the companies in the same industry.
Industry RankSector Rank
ROA -33.01%
ROE -68.46%
ROIC 0.8%
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • CETX has a Operating Margin (0.54%) which is in line with its industry peers.
  • CETX's Gross Margin of 40.83% is fine compared to the rest of the industry. CETX outperforms 70.16% of its industry peers.
  • CETX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.54%
PM (TTM) N/A
GM 40.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

3

2. CETX Health Analysis

2.1 Basic Checks

  • CETX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for CETX has been increased compared to 1 year ago.
  • CETX has more shares outstanding than it did 5 years ago.
  • CETX has a better debt/assets ratio than last year.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200K 400K 600K 800K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -0.71, we must say that CETX is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CETX (-0.71) is worse than 79.03% of its industry peers.
  • A Debt/Equity ratio of 0.28 indicates that CETX is not too dependend on debt financing.
  • CETX's Debt to Equity ratio of 0.28 is on the low side compared to the rest of the industry. CETX is outperformed by 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z -0.71
ROIC/WACC0.09
WACC8.99%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.38 indicates that CETX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.38, CETX is in line with its industry, outperforming 50.81% of the companies in the same industry.
  • A Quick Ratio of 1.96 indicates that CETX should not have too much problems paying its short term obligations.
  • CETX has a Quick ratio of 1.96. This is comparable to the rest of the industry: CETX outperforms 55.65% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.96
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

3

3. CETX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 99.97% over the past year.
  • Looking at the last year, CETX shows a very strong growth in Revenue. The Revenue has grown by 23.78%.
  • The Revenue has been growing by 11.95% on average over the past years. This is quite good.
EPS 1Y (TTM)99.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.79%
Revenue 1Y (TTM)23.78%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%17.42%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 2M -2M 4M -4M -6M

4

4. CETX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 0.60 indicates a rather cheap valuation of CETX.
  • CETX's Price/Forward Earnings ratio is rather cheap when compared to the industry. CETX is cheaper than 98.39% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CETX to the average of the S&P500 Index (38.68), we can say CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.6
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CETX indicates a rather cheap valuation: CETX is cheaper than 96.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.76
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CETX Dividend Analysis

5.1 Amount

  • No dividends for CETX!.
Industry RankSector Rank
Dividend Yield 0%

CETX Fundamentals: All Metrics, Ratios and Statistics

CEMTREX INC

NASDAQ:CETX (4/21/2026, 3:24:40 PM)

1.2201

-0.07 (-5.42%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-13
Earnings (Next)05-13
Inst Owners2.26%
Inst Owner Change-1.8%
Ins OwnersN/A
Ins Owner Change0%
Market Cap12.30M
Revenue(TTM)78.88M
Net Income(TTM)-19.91M
Analysts82.86
Price TargetN/A
Short Float %5.26%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.6
P/S 0.16
P/FCF N/A
P/OCF 26.31
P/B 0.42
P/tB 0.48
EV/EBITDA 3.76
EPS(TTM)-2.67
EYN/A
EPS(NY)2.05
Fwd EY168.04%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.05
OCFY3.8%
SpS7.83
BVpS2.89
TBVpS2.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -33.01%
ROE -68.46%
ROCE 1.01%
ROIC 0.8%
ROICexc 1.55%
ROICexgc 1.87%
OM 0.54%
PM (TTM) N/A
GM 40.83%
FCFM N/A
ROA(3y)-31.62%
ROA(5y)-27.6%
ROE(3y)-199.93%
ROE(5y)-145.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y0.85%
F-Score5
Asset Turnover1.31
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA 4.33
Cap/Depr 153.62%
Cap/Sales 2.78%
Interest Coverage 0.45
Cash Conversion 25.2%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.96
Altman-Z -0.71
F-Score5
WACC8.99%
ROIC/WACC0.09
Cap/Depr(3y)194.3%
Cap/Depr(5y)152.34%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.79%
EPS Next Y265.45%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.78%
Revenue growth 3Y14.99%
Revenue growth 5Y11.95%
Sales Q2Q%17.42%
Revenue Next Year15%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y106.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y123.35%
OCF growth 3YN/A
OCF growth 5YN/A

CEMTREX INC / CETX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CEMTREX INC?

ChartMill assigns a fundamental rating of 3 / 10 to CETX.


Can you provide the valuation status for CEMTREX INC?

ChartMill assigns a valuation rating of 4 / 10 to CEMTREX INC (CETX). This can be considered as Fairly Valued.


How profitable is CEMTREX INC (CETX) stock?

CEMTREX INC (CETX) has a profitability rating of 2 / 10.


How financially healthy is CEMTREX INC?

The financial health rating of CEMTREX INC (CETX) is 3 / 10.